its costs are the learning curve, the equipment, and the infection risk inherent to any injection
doi:10.1016/j.jsmc.2016.10.004 Muscogiuri G, Barrea L, Annunziata G, et al
Key Takeaways Foundayo (orforglipron), approved April 1st, is the first small molecule oral GLP-1 no empty stomach requirement, no cold chain, and potentially lower production costs long-term
Experimental hypothyroid models, including T3/T4 withdrawal and TH receptor (TR/) knockout mice, show spontaneous hepatic collagen accumulation and elevated expression of pro-fibrotic genes, confirming that TH deficiency alone can drive ECM remodeling
In other words, if the advertiser claims to have a specific level of support (e.g., clinical studies), then the complaint may still challenge the claims as lacking adequate substantiation